China Animal Health Market, By Pharmaceuticals

Growth Outlook

• The China Animal Health Market, By Pharmaceuticals market is on a steady long-term growth path. Segment value stands at roughly USD 2016 Mn in 2026 and is projected to reach USD 2145 Mn by 2027 — a gain of about 6% over the forecast period, translating to a CAGR in the mid-single digits.
• What the regional split looks like (2026): Parasiticides leads, holding roughly 39% of segment value — the single largest regional share. Others is the second-largest contributor. Anti-Infectives, Anti-Inflammatory and Analgesics make up the remainder, in descending order.
• By 2027, Parasiticides alone is expected to reach USD 838 Mn, with Others at USD 463 Mn.

Market Dynamics

China's animal health market has seen a tremendous growth in recent years, driven by the demand for high-quality and safe animal pharmaceuticals. The increasing awareness among consumers about the importance of pet care and the government's focus on improving animal welfare have also played a significant role in the growth of this market.

The demand for animal health pharmaceuticals in China is mainly driven by the rising pet ownership in the country. According to the China Pet Industry White Paper, the number of pet owners in China has reached approximately 100 million, with an estimated annual spending of around 200 billion yuan on their pets. This growing trend of pet ownership has led to an increase in demand for animal health products, including vaccines, dietary supplements, and prescription drugs.

Another factor driving the demand for animal health pharmaceuticals in China is the rising concerns about food safety. With the frequent occurrence of food scandals and contamination, consumers are becoming more conscious about the origin and quality of the food they consume. This has resulted in a higher demand for animal health products that can ensure the safety and quality of the animal products in the market.

The Chinese government has also recognized the importance of animal health and is taking significant steps to improve animal welfare in the country. In 2018, the Chinese Ministry of Agriculture and Rural Affairs released a draft regulation on the management of animal vaccines and veterinary drugs, with the aim of enhancing the safety and efficacy of these products. This step has not only contributed towards the development of a more regulated and efficient animal health market but has also increased the demand for high-quality animal pharmaceuticals.

Moreover, the outbreak of diseases such as African swine fever and bird flu has highlighted the need for better animal disease control and management in China. This has led to an increased demand for animal health products, especially vaccines, to prevent and control the spread of such diseases.

In addition to the domestic demand, China's animal health market also presents lucrative opportunities for international pharmaceutical companies. The growing economy and rising disposable income in China have resulted in a shift towards premium and imported animal health products. This has created a favorable market for foreign companies to enter and expand their presence in the Chinese market.

In conclusion, the demand for animal health pharmaceuticals in China is driven by various factors, including the rise in pet ownership, food safety concerns, government initiatives, and disease outbreaks. With the continued efforts towards improving animal welfare and the increasing demand for premium products, the animal health market in China is expected to witness significant growth in the coming years.